Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

UNITED THERAPEUTICS (UTHR) Debt to Equity: 2010-2024

Historic Debt to Equity for UNITED THERAPEUTICS (UTHR) over the last 12 years, with Dec 2024 value amounting to $0.05.

  • UNITED THERAPEUTICS's Debt to Equity fell 73.86% to $0.03 in Q1 2025 from the same period last year, while for Mar 2025 it was $0.21, marking a year-over-year decrease of 62.14%. This contributed to the annual value of $0.05 for FY2024, which is 60.20% down from last year.
  • UNITED THERAPEUTICS's Debt to Equity amounted to $0.05 in FY2024, which was down 60.20% from $0.12 recorded in FY2023.
  • UNITED THERAPEUTICS's 5-year Debt to Equity high stood at $0.24 for FY2020, and its period low was $0.05 during FY2024.
  • Moreover, its 3-year median value for Debt to Equity was $0.12 (2023), whereas its average is $0.11.
  • Data for UNITED THERAPEUTICS's Debt to Equity shows a maximum YoY crashed of 60.20% (in 2024) over the last 5 years.
  • Over the past 5 years, UNITED THERAPEUTICS's Debt to Equity (Yearly) stood at $0.24 in 2020, then declined by 14.24% to $0.20 in 2021, then dropped by 17.47% to $0.17 in 2022, then dropped by 29.87% to $0.12 in 2023, then plummeted by 60.20% to $0.05 in 2024.